When I would see male diabetes patients in the endocrinologist’s office, we would always order a testosterone level as part of the labs. It seemed that regardless of the severity of their diabetes or their age, the majority of these men had low levels. The association between low testosterone and …

Recently a pump user reported a sudden increase in her glucose levels lasting a couple of days. Her blood sugars were elevated to 275-320mg/dL, with no ketones present.  Changing her infusion sets did not help. Nor did rotating to a new injection site or even using a fresh vial of insulin. After reviewing her insulin pump we noticed a symbol on her “home screen” saying that a special feature was running.

50-80% basal rate reduction lowers the risk of exercise-induced hypoglycemia.

Intensive insulin-adherence interventions that target type 2 diabetes patients with high risk of noncompliance can be beneficial.

Can testosterone treatment benefit men at risk of developing insulin resistance?

In this Exclusive Interview, Sam Engel talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about diabetes drugs in the pipeline at Merck; clinical trials on sitagliptin and ertugliflozin, including the CompoSIT and VERSIS studies; and the problem of "clinical inertia" in intensifying treatment.

In this Exclusive Interview transcript, Sam Engel talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about how clinical inertia affects diabetes treatment; clinical trials on sitagliptin and ertugliflozin, including the CompoSIT and VERSIS studies; and diabetes drugs in the Merck pipeline.

In addition, high-fat, low-carb breakfast tied to less hunger later in the day

Improvement seen in some self-reported health behaviors but not clinical health markers, health care utilization